Park Square has placed David McMullin as Senior Vice President, Corporate Development and Strategy at Aldeyra Therapeutics.
| less than a minute read
Aldeyra Therapeutics Appoints David McMullin As Senior Vice President, Corporate Development And Strategy
Get in touch
Get in touch
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, announced the hiring of David McMullin to the newly created position of Senior Vice President, Corporate Development and Strategy. Mr. McMullin will be responsible for leading Aldeyra's commercial planning, corporate development, and business development efforts.
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-15-32-04-091-6a7205f4b4306b41266d92f2.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-18-23-13-222-6a722e11663e81e26a6b2c3e.jpg)
